Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.
about
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseStandardization of Neisseria meningitidis serogroup B colorimetric serum bactericidal assaySerum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines.Review of meningococcal group B vaccines.Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.Humoral immune responses to Neisseria meningitidis in children.Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis.Comparative analysis of two meningococcal immunotyping monoclonal antibodies by resonant mirror biosensor and antibody gene sequencingImportance of complement source in measuring meningococcal bactericidal titers.Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein.Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine.Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity.Attachment and invasion of Neisseria meningitidis to host cells is related to surface hydrophobicity, bacterial cell size and capsule.Protection by meningococcal outer membrane protein PorA-specific antibodies and a serogroup B capsular polysaccharide-specific antibody in complement-sufficient and C6-deficient infant ratsDisparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine.Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assay.Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal diseaseStandardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccineBactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assaySingle nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine.Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccineInteraction of complement with Neisseria meningitidis and Neisseria gonorrhoeaeCurrent status of meningococcal group B vaccine candidates: capsular or noncapsular?Routinely vaccinating adolescents against meningococcus: targeting transmission & diseaseInstability of expression of lipooligosaccharides and their epitopes in Neisseria gonorrhoeae.Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection.Electromorphic characterization and description of conserved epitopes of the lipooligosaccharides of group A Neisseria meningitidis.Immune responses in mice to different noncovalent complexes of meningococcal B polysaccharide and outer membrane proteins.Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides.Stability of expression of Neisseria gonorrhoeae lipooligosaccharidesElaboration of a 3.6-kilodalton lipooligosaccharide, antibody against which is absent from human sera, is associated with serum resistance of Neisseria gonorrhoeae.Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotypingDevelopment of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse modelHuman opsonins to meningococci after vaccination.
P2860
Q26995760-7ADD2ECC-4D29-4C1B-9835-28C21CD1A826Q28344521-80FEC58A-2261-4137-8BCD-B477F72E7E7AQ33601858-DF6E1E26-2B93-4879-B2A3-29F65BBD484CQ33646965-9FC7A3B0-F652-48F1-A614-9B8850C580D6Q33753424-97BDD7CC-372A-4374-A8AF-A6A97176B966Q33867340-A5F1D7FF-18CF-4E5A-8F17-37ADD279A11EQ33946852-3E172333-48AB-4133-B069-9B3C15F51BECQ33968762-BCFEF9A1-5B86-41A4-82C7-C228DB6626C9Q33997977-6C767756-63D6-4AB0-B939-30CA3E60AC63Q33999159-1CE37A93-7A19-4A96-8711-F4008371F194Q34001933-6B0BB39D-481A-4893-ADA9-06E87A5E705BQ34007332-ABD412BA-319C-4F62-B565-22359E3A5D36Q34116994-37498417-0833-4D78-ABC0-7FB3A8D92426Q34547078-7DDB20FA-3FBA-4B26-827F-43F73195D833Q34584506-543D8E7D-7087-49C9-BE26-3C513D223ED3Q34602010-CDB80742-E33F-462F-8F94-7D19A2D4D800Q35013077-D0BD2547-B1D0-41F3-B1EA-D41B87E3D2EBQ35138700-1CD111BA-F315-4FCC-B544-F9C665543AA6Q35224881-75D0D40F-1AFC-43BD-B8A4-9A78EF8CB885Q35229074-7938BFB2-5939-4B8D-A388-BF1723A1F9C7Q35273041-D3B1D732-BA39-4387-BED0-D99CBA97E2DDQ35454550-3D307756-D300-4A5E-94F6-72A64BA21754Q35544353-0B28CE6B-9CC2-4472-969B-3BE9B81295B2Q35783578-3CFCE261-C197-4093-A53D-FB0BAF918D93Q35805284-DD7FAD17-79E6-4C0A-9408-25B820A03EA4Q35946870-EB06098B-47D4-4EB7-8FA5-C6AED322C566Q36464572-96DCCDF2-67C6-4D42-95BF-E3C22C1D4918Q36633889-18E2D4B3-2663-4A46-A18C-37C5CB59F183Q36642138-F1EADD21-E76A-42B9-B1B4-27554797855FQ36825737-CA0255CD-825E-48E8-BAD5-CC71FC9D3E79Q36996215-964D454E-E7F6-4986-8B7F-7F9D057304A7Q36997996-5CFD4F38-2AF4-431A-8015-FF3DAB37B52CQ36999872-04B862C5-84BD-4EC9-A4FB-17AE02A4733CQ37002443-D10E4F03-B64E-47E1-A0E2-395A60FF440FQ37011910-7FB09F21-1DE8-4A00-976D-56122AB28D7EQ37014443-60F80A49-B6B8-4A36-B9C4-A53C8B1C4DFEQ37031361-D6869B1E-4FD8-456F-805E-AD33E58D1209Q37039262-040200FC-5167-40D9-9DD2-61115DC4AE2FQ37041494-EBBE24E7-192E-4E87-874E-5E2A52AAD8C7Q37042683-912C326F-AEE8-44BC-9043-CD7586008FB2
P2860
Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Importance of complement sourc ...... coccal group B polysaccharide.
@en
type
label
Importance of complement sourc ...... coccal group B polysaccharide.
@en
prefLabel
Importance of complement sourc ...... coccal group B polysaccharide.
@en
P2860
P1476
Importance of complement sourc ...... ococcal group B polysaccharide
@en
P2093
Mandrell RE
Zollinger WD
P2860
P304
P407
P577
1983-04-01T00:00:00Z